These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 10926735)

  • 1. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
    Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
    Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
    Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
    J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
    Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T;
    J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
    Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
    Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
    N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Kang S; Lucky AW; Pariser D; Lawrence I; Hanifin JM
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S58-64. PubMed ID: 11145796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.
    Soter NA; Fleischer AB; Webster GF; Monroe E; Lawrence I
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S39-46. PubMed ID: 11145794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe treatment of head/neck AD with tacrolimus ointment.
    Kang S; Paller A; Soter N; Satoi Y; Rico MJ; Hanifin JM
    J Dermatolog Treat; 2003 Jun; 14(2):86-94. PubMed ID: 12775315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.
    Boguniewicz M; Fiedler VC; Raimer S; Lawrence ID; Leung DY; Hanifin JM
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):637-44. PubMed ID: 9802373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy.
    Hanifin JM; Ling MR; Langley R; Breneman D; Rafal E
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S28-38. PubMed ID: 11145793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus ointment monotherapy in chinese children with atopic dermatitis.
    Yeung CK; Ma KC; Chan HH
    Skinmed; 2006; 5(1):12-7. PubMed ID: 16522977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis.
    Sugiura H; Uehara M; Hoshino N; Yamaji A
    Br J Dermatol; 2001 Nov; 145(5):795-8. PubMed ID: 11736904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.